Skip to Content

Background Library

We offer you detailed press kits with a lot of background information, downloads, and contacts.

Topics

CompanyPersonalised healthcareVirology
DiabetesResearch & Development
OncologyRheumatoid arthritis

In Focus: Oncology

Bevacizumab, the antibody in the anti-tumour drug Avastin

Bevacizumab, the antibody in the anti-tumour drug Avastin

The Roche Group is the world’s leading provider of cancer care products. Our anti-cancer medicines are saving lives and significantly advancing the way some cancers are treated. The Roche portfolio currently includes five innovative cancer products proven to provide survival benefit in a number of different tumor types: Avastin® (bevacizumab), Herceptin® (trastuzumab), Xeloda® (capecitabine), MabThera® (rituximab) and Tarceva® (erlotinib).
more